| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.39 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |